Hitoshi Ishizuka - Concepedia

Author

Hitoshi Ishizuka

Daiichi-Sankyo (Japan)

Also Known As

H Ishizuka, H. Ishizuka, Hiroya Ishizuka, Hitoshi ISHIZUKA, Hitoshi Ishizuka, Ishizuka Hitoshi

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Daiichi-Sankyo (Japan)Daiichi Sankyo (Germany)SOUSEIKAI Global Clinical Research Center Osaka Hospital The University of Tokyo

About

Hitoshi Ishizuka is an author at Daiichi-Sankyo (Japan) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	565
2	Natural Sciences	3	3	338
3	Social Sciences	2	2	23
4	Health Sciences	1	1	24
5	Public Health	1	1	32

Hitoshi Ishizuka

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Transcriptional Control of Intestinal Cytochrome P-4503A by 1α,25-Dihydroxy Vitamin D3 Kenneth E. Thummel, Cynthia Brimer, Kazuto Yasuda, Molecular Pharmacology	2001	323
GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum (II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. Toshihisa Ishikawa, C. David Wright, Hitoshi Ishizuka Journal of Biological Chemistry Cell DifferentiationCellular PhysiologyTumor BiologyMyeloid NeoplasiaHematological Malignancy	1994	207
Mechanism of the down-regulation of cAMP receptor protein by glucose in Escherichia coli: role of autoregulation of the crp gene. Hitoshi Ishizuka, Akemi Hanamura, Toshifumi Inada, The EMBO Journal Molecular PhysiologySignal TransductionBiochemistryCamp Receptor ProteinCrp Gene	1994	109
P-Glycoprotein-Mediated Transport of Itraconazole across the Blood-Brain Barrier Tetsuo Miyama, Hitomi Takanaga, Hirotami Matsuo, Antimicrobial Agents and Chemotherapy	1998	105
A lowered concentration of cAMP receptor protein caused by glucose is an important determinant for catabolite repression in <i>Escherichia coli</i> Hitoshi Ishizuka, Akemi Hanamura, Tadashi Kunimura, Molecular Microbiology	1993	102
Temocaprilat, a Novel Angiotensin-Converting Enzyme Inhibitor, is Excreted in Bile via an ATP-dependent Active Transporter (cMOAT) That is Deficient in Eisai Hyperbilirubinemic Mutant Rats (EHBR) Hitoshi Ishizuka, K Konno, Hideo Naganuma, Journal of Pharmacology and Experimental Therapeutics	1997	86
Species Differences in the Transport Activity for Organic Anions across the Bile Canalicular Membrane Hitoshi Ishizuka, K Konno, Tetsuo Shiina, Journal of Pharmacology and Experimental Therapeutics	1999	81
Transport of Temocaprilat into Rat Hepatocytes: Role of Organic Anion Transporting Polypeptide Hitoshi Ishizuka, K Konno, Hideo Naganuma, Journal of Pharmacology and Experimental Therapeutics	1998	67
Clinical Pharmacokinetics of Laninamivir, a Novel Long‐Acting Neuraminidase Inhibitor, After Single and Multiple Inhaled Doses of Its Prodrug, CS‐8958, in Healthy Male Volunteers Hitoshi Ishizuka, Satoshi Yoshiba, Hiromi Okabe, The Journal of Clinical Pharmacology Healthy Male VolunteersPharmacologyAntiviral Drug DevelopmentAntimicrobial ResistanceAntiviral Therapy	2010	66
Identification of Circulating miRNAs Differentially Regulated by Opioid Treatment Kaoru Toyama, Naoki Kiyosawa, Kenji Watanabe, International Journal of Molecular Sciences InflammationMolecular PharmacologyEpigenetic RegulationMedicinePlasma Mirna Profiles	2017	52

Page 1